צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים: Palatin Corp (PTN)

Palatin Technologies (PTN) relies on global peptide supply chains to protect its margins. The rolling annual sales growth rate illustrates the struggle against competitors in the narrow women's health segment, where the metric value stands at -47.60. However, limited pricing power and pressure from insurers are forcing the company to implement aggressive discounts, which constrains future revenue dynamics.
פילוחי נתונים אנליטיים מרוכזים עבור Palatin (PTN)

The specifics of proprietary drug development for women's health at Palatin Technologies (PTN) drive the volatility of the LTM sales growth YoY, which currently stands at -47.60. This metric measures the percentage change in revenue over a rolling 12-month period, allowing investors to assess the actual speed of business scaling and timely align expansion rates with industry macroeconomic risks.